News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
139,285 Results
Type
Article (6828)
Company Profile (11)
Press Release (132482)
Multimedia
Podcasts (10)
Webinars (3)
Section
Business (45392)
Career Advice (362)
Deals (7843)
Drug Delivery (23)
Drug Development (16595)
Employer Resources (37)
FDA (3081)
Job Trends (2698)
News (67250)
Policy (5905)
Tag
2027 BioCapital Standard (1)
2027 Pharm Country Standard (1)
Academia (422)
Accelerated approval (10)
ADA (2)
Adcomms (4)
Allergies (49)
Alliances (12863)
ALS (53)
Alzheimer's disease (471)
Antibody-drug conjugate (ADC) (155)
Approvals (3269)
Artificial intelligence (252)
ASCO (77)
Autoimmune disease (86)
Automation (14)
Bankruptcy (49)
Best Places to Work (2091)
BIO (19)
BIOSECURE Act (4)
Biosimilars (117)
Biotechnology (8)
Bladder cancer (72)
Brain cancer (14)
Breast cancer (155)
Cancer (1532)
Cardiovascular disease (104)
Career advice (326)
Career pathing (14)
CAR-T (74)
CDC (4)
Cell therapy (208)
Cervical cancer (6)
Clinical research (14971)
Collaboration (682)
Commercialization (1)
Compensation (45)
Complete response letters (14)
COVID-19 (590)
CRISPR (18)
C-suite (246)
Cystic fibrosis (23)
Data (2052)
Denatured (5)
Depression (37)
Dermatology (28)
Diabetes (122)
Diagnostics (1529)
Digital health (29)
Diversity (1)
Diversity, equity & inclusion (5)
Drug discovery (108)
Drug pricing (16)
Drug shortages (3)
Duchenne muscular dystrophy (60)
Earnings (15120)
Editorial (7)
Employer branding (3)
Employer resources (29)
Events (17850)
Executive appointments (232)
FDA (4072)
Fibrodysplasia Ossificans Progressiva (2)
Frontotemporal dementia (8)
Funding (474)
Gene editing (56)
Generative AI (20)
Gene therapy (157)
GLP-1 (206)
Government (682)
Grass and pollen (2)
Guidances (107)
Healthcare (3210)
Hematology (36)
HIV (16)
Huntington's disease (8)
IgA nephropathy (30)
Immunology and inflammation (54)
Immuno-oncology (22)
Indications (58)
Infectious disease (652)
Inflammatory bowel disease (65)
Inflation Reduction Act (4)
Influenza (28)
Intellectual property (82)
Interviews (61)
IPO (3010)
IRA (4)
Job creations (686)
Job search strategy (260)
JPM (19)
Kidney cancer (9)
Labor market (15)
Layoffs (69)
Leadership (10)
Legal (1370)
Liver cancer (32)
Longevity (14)
Lung cancer (235)
Lymphoma (110)
Machine learning (18)
Management (13)
Manufacturing (337)
Marketing (4)
MASH (38)
Medical device (2852)
Medtech (2953)
Mergers & acquisitions (5185)
Metabolic disorders (292)
mRNA (37)
Multiple sclerosis (39)
NASH (3)
Neurodegenerative disease (145)
Neuropsychiatric disorders (20)
Neuroscience (901)
Neurotech (1)
NextGen: Class of 2026 (1026)
Non-profit (465)
Now hiring (5)
Obesity (114)
Opinion (64)
Ovarian cancer (64)
Pain (39)
Pancreatic cancer (82)
Parkinson's disease (165)
Partnered (16)
Patents (135)
Patient recruitment (153)
Peanut (11)
People (10474)
Pharmaceutical (3)
Pharmacy benefit managers (8)
Phase 1 (4410)
Phase 2 (6734)
Phase 3 (5158)
Pipeline (2657)
Policy (43)
Postmarket research (447)
Preclinical (1887)
Press Release (10)
Prostate cancer (103)
Psychedelics (8)
Radiopharmaceuticals (163)
Rare diseases (237)
Real estate (1307)
Recruiting (20)
Regulatory (5190)
Reports (10)
Research institute (357)
Resumes & cover letters (45)
Rett syndrome (4)
RNA editing (14)
RSV (8)
Schizophrenia (55)
Series A (98)
Series B (70)
Service/supplier (3)
Sickle cell disease (23)
Special edition (1)
Spinal muscular atrophy (15)
Sponsored (11)
Startups (994)
Stomach cancer (2)
Supply chain (41)
Tariffs (15)
The Weekly (5)
Vaccines (177)
Venture capital (32)
Weight loss (52)
Women's health (23)
Worklife (9)
Date
Today (22)
Last 7 days (99)
Last 30 days (392)
Last 365 days (6388)
2026 (3762)
2025 (6283)
2024 (7481)
2023 (8266)
2022 (12205)
2021 (12223)
2020 (11441)
2019 (8840)
2018 (6646)
2017 (6712)
2016 (6076)
2015 (7160)
2014 (5238)
2013 (4451)
2012 (4664)
2011 (4993)
2010 (4474)
Location
Africa (185)
Alabama (61)
Alaska (1)
Arizona (44)
Arkansas (5)
Asia (25366)
Australia (3210)
California (2181)
Canada (919)
China (645)
Colorado (77)
Connecticut (117)
Delaware (48)
Europe (22965)
Florida (455)
Georgia (83)
Hawaii (1)
Idaho (3)
Illinois (177)
India (60)
Indiana (118)
Iowa (2)
Japan (387)
Kansas (14)
Kentucky (8)
Louisiana (15)
Maine (8)
Maryland (298)
Massachusetts (1810)
Michigan (76)
Minnesota (152)
Mississippi (2)
Missouri (24)
Montana (1)
Nebraska (6)
Nevada (37)
New Hampshire (30)
New Jersey (956)
New Mexico (3)
New York (629)
North Carolina (336)
Northern California (1070)
Ohio (62)
Oklahoma (2)
Oregon (5)
Pennsylvania (426)
Puerto Rico (2)
Rhode Island (7)
South America (249)
South Carolina (10)
Southern California (888)
Tennessee (32)
Texas (468)
United States (8889)
Utah (140)
Vermont (1)
Virginia (98)
Washington D.C. (10)
Washington State (158)
West Virginia (2)
Wisconsin (32)
Wyoming (1)
139,285 Results for "alpha pro tech ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2025 Financial Results
March 12, 2026
·
18 min read
Press Releases
Alpha Pro Tech, Ltd. Announces Third Quarter 2025 Financial Results
November 6, 2025
·
12 min read
Press Releases
Shanghai Kinbio Tech Co., Ltd. Announces Strategic Expansion with New Kinbionova Showroom in San Diego
July 8, 2026
·
1 min read
Business
Alpha Pro Tech, Ltd. Announces Third Quarter 2023 Financial Results
Alpha Pro Tech, Ltd. announced financial results for the three and nine month period ended September 30, 2023.
November 7, 2023
·
18 min read
Business
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2023 Financial Results
Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three month period and year ended December 31, 2023.
March 13, 2024
·
18 min read
Press Releases
KyooBe Tech Advances New Method for Vaccine Development
Leinfelden, Germany. Recent infectious disease events—from hantavirus outbreaks and meningitis cases to recurring disease outbreaks in livestock farming—highlight the need for flexibly scalable vaccine manufacturing processes. To address this challenge, Stuttgart-based technology company KyooBe Tech has developed a platform designed to accelerate vaccine production. This technology is now also available to external users for studies at the Fraunhofer Institute for Cell Therapy and Immunology (IZI).
June 30, 2026
·
1 min read
Business
Alpha Pro Tech, Ltd. Announces Second Quarter 2023 Financial Results
Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three and six month periods ended June 30, 2023.
August 8, 2023
·
20 min read
Press Releases
Alpha Tau and Tolmar Announce Strategic Collaboration to Bring Alpha DaRT® Therapy to U.S. Urological Cancer Patients
June 3, 2026
·
10 min read
Business
Alpha Pro Tech, Ltd. Announces First Quarter 2023 Financial Results
Alpha Pro Tech, Ltd., a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, announced financial results for the three month period ended March 31, 2023.
May 9, 2023
·
16 min read
Press Releases
Alpha Tau Announces Strong Overall Survival Results from Alpha DaRT® Pancreatic Cancer Studies Presented at 2026 ASCO Annual Meeting
June 1, 2026
·
12 min read
1 of 13,929
Next
